Literature DB >> 25055830

The trouble with dabigatran.

Blake Charlton1, Rita Redberg2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25055830     DOI: 10.1136/bmj.g4681

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  Hierarchical Models for Multiple, Rare Outcomes Using Massive Observational Healthcare Databases.

Authors:  Trevor R Shaddox; Patrick B Ryan; Martijn J Schuemie; David Madigan; Marc A Suchard
Journal:  Stat Anal Data Min       Date:  2016-07-17       Impact factor: 1.051

2.  The criteria of the Italian Federation of Thrombosis Centres on DOACs: a "real world" application in nonvalvular atrial fibrillation patients already on vitamin K antagonist.

Authors:  Doris Barcellona; Miro Luzza; Nicola Battino; Lara Fenu; Francesco Marongiu
Journal:  Intern Emerg Med       Date:  2014-12-09       Impact factor: 3.397

3.  Use of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data.

Authors:  Claudia Stöllberger; Roman Brooks; Josef Finsterer; Thomas Pachofszky
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

Review 4.  Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation.

Authors:  Francesco Violi; Daniele Pastori; Pasquale Pignatelli
Journal:  J Atr Fibrillation       Date:  2014-10-31

5.  Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.

Authors:  Angela Spelsberg; Christof Prugger; Peter Doshi; Kerstin Ostrowski; Thomas Witte; Dieter Hüsgen; Ulrich Keil
Journal:  BMJ       Date:  2017-02-07

6.  Dabigatran Etexilate Induces Cytotoxicity in Rat Gastric Epithelial Cell Line via Mitochondrial Reactive Oxygen Species Production.

Authors:  Hiromi Kurokawa; Atsushi Taninaka; Hidemi Shigekawa; Hirofumi Matsui
Journal:  Cells       Date:  2021-09-22       Impact factor: 6.600

7.  The Dabigatran debate.

Authors:  Riyaz A Kaba; Farhana Ara; David E Ward; Subo Emanuel
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

8.  Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data.

Authors:  Merlijn W J van Leent; Jelena Stevanović; Frank G Jansman; Maarten J Beinema; Jacobus R B J Brouwers; Maarten J Postma
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

9.  Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.

Authors:  Subramanian Yegneswaran; Yajnavalka Banerjee; José A Fernández; Hiroshi Deguchi; John H Griffin
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.